SS Innovations International (SSII) vs Utah Medical Products (UTMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Utah Medical Products (UTMD) has outperformed SS Innovations International (SSII) over the past year, gaining 26.0% versus a loss of 78.7%. SS Innovations International is the larger company by market cap ($254.9 million vs $198.0 million), about 1.3 times the size. Utah Medical Products pays a dividend yielding 1.78%, while SS Innovations International does not currently pay one.
Utah Medical Products converts more of its revenue into profit, with a net margin of 29.3% versus -28.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SSII | UTMD |
|---|---|---|
| Share price | $1.27 | $69.49 |
| Market cap | $254.86M | $198.01M |
| 1-day change | -0.78% | -2.07% |
| YTD return | -77.64% | +24.18% |
| 1-year return | -78.69% | +25.98% |
| 5-year return | — | -42.25% |
| P/E ratio (TTM) | — | 20.81 |
| EPS (TTM) | $-0.07 | $3.34 |
| Dividend yield | 0.00% | 1.78% |
| Annual dividend | $0.00 | $1.24 |
| Revenue (latest FY) | $42.48M | $38.52M |
| Revenue growth (YoY) | +105.74% | -5.83% |
| Net income (latest FY) | $-12.13M | $11.29M |
| Gross margin | 46.00% | 57.12% |
| Operating margin | -19.29% | 29.60% |
| Net margin | -28.55% | 29.30% |
| 52-week high | $6.79 | $76.89 |
| 52-week low | $1.12 | $53.80 |
| Distance from 52-week high | -81.30% | -9.62% |
| Analyst consensus | none | — |
| Avg. price target upside | +451.18% | — |
| Average volume | 86.18K | 33.70K |
| Shares outstanding | 200.68M | 2.85M |
| Employees | 483 | 140 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- UTMD has outperformed SSII by 104.7 percentage points over the past year.
- Utah Medical Products offers a meaningfully higher dividend yield (1.78% vs 0.00%).
- Utah Medical Products is more profitable, keeping 29.3 cents of every revenue dollar as net income versus -28.5 cents for SS Innovations International.
- SS Innovations International grew revenue faster in its latest fiscal year (+105.74% vs -5.83%).
About SS Innovations International
SSII stock →SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems.
Health Care · Medical/Dental Instruments · 483 employees
About Utah Medical Products
UTMD stock →Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally.
Health Care · Medical/Dental Instruments · 140 employees
SSII vs UTMD FAQ
Which is bigger, SS Innovations International or Utah Medical Products?
SS Innovations International (SSII) is larger, with a market capitalization of $254.86M compared with $198.01M for Utah Medical Products (UTMD).
Which stock has performed better over the past year, SSII or UTMD?
UTMD returned +25.98% over the past 12 months, compared with -78.69% for SSII (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, SS Innovations International or Utah Medical Products?
Utah Medical Products pays a dividend yielding 1.78%, while SS Innovations International does not currently pay a regular dividend.
Are SS Innovations International and Utah Medical Products in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.